Rationale and Objectives. We assessed the role that nitric oxide (NO)
plays in contrast media (CM) toxicity, using 100% lethal dose (LD(100)
) studies in hyperimmune Brown Norway (BN) rats. Methods. Ninety-two B
N rats and 41 Sprague-Dawley (SD) rats underwent CM LD(100) tail vein
injections with methylglucamine iothalamate or sodium iothalamate to t
he point of cessation of respiration. Methylglucamine hydrochloride al
so nas injected. The injections were accompanied by L-arginine (L-Arg)
or D-arginine (D-Arg) analogues or by an H-1 blocker. L-Arg analogues
inhibit NO formation, and D-Arg analogues do not. Results. An L-Arg a
nalogue, but not a D-Arg analogue, increased the tolerance of BN rats
(p < .005) for methylglucamine iothalamate but not for sodium iothalam
ate. The L-Arg analogue also protected BN rats against methylglucamine
chloride injections (p < .002). H-1 blockade protected BN rats agains
t methylglucamine iothalamate (p < .0005) and methylglucamine chloride
(p < .005) injections. None of these measures altered the CM toleranc
e of SD rats. In SD rats, injections of either methylglucamine iothala
mate or sodium iothalamate along with a D-Arg analogue or normal salin
e were better tolerated than similar injections in BN rats (p < .01 an
d .002 for methylglucamine iothalamate and sodium iothalamate: respect
ively). In SD rats but not BN rats, sodium iothalamate was better tole
rated than was methylglucamine iothalamate (p < .0005). Conclusion. NO
appears to play a significant role in BN rats' LD(100) CM toxicity an
d has been implicated by others in the blood pressure fall characteriz
ing some forms of antigen-induced anaphylaxis [1, 2]. The results of t
he current study and the literature suggest that methylglucamine-modul
ated release of histamine from mast cells may underlie the NO producti
on.